Showing 34,776 results

Resistance

Drug-resistance or viral-load testing required before switch to dolutegravir in Togo

News
16 December 2019
HIV treatment for children & young people

ViiV Healthcare files submissions to the FDA and EMA for the first-ever dispersible formulation of dolutegravir (DTG) for children living with HIV

Editor's pick
ViiV press release
15 December 2019
Epidemiology & behaviour

Marked changes in gay men’s relationship agreements and condom use in the PrEP era

News
13 December 2019
Improving HIV care

Community-led research finds poor quality of HIV services in 14 low-and middle-income countries

News
12 December 2019

HIV update - 12th December 2019

December 2019
Exposure to HIV through medical procedures

How to Keep America's Blood Banks HIV-Free While Letting All Gay Men Donate

Editor's pick
TheBodyPro
11 December 2019
Economic & social inequality

Urbanisation of rural Uganda is driving HIV in the country

Editor's pick
Avert
11 December 2019
PrEP science

Facebook ads push misinformation about HIV prevention drugs, LGBT activists say, ‘harming public health’

Editor's pick
Washington Post
10 December 2019
HIV treatment for children & young people

Protesting for Pediatric Treatment: an Interview with Maurine Murenga

Editor's pick
Health GAP (Global Access Project)
10 December 2019
Access to healthcare

FDA Releases Analysis of HIV Drug Approval Program for Low-Income Countries

Editor's pick
Contagion Live
10 December 2019
Access to healthcare

London: People Are Struggling To Access At-Home STI Tests Due To Daily Caps

Editor's pick
HuffPost
10 December 2019
Changing treatment

Lipid increases after switching from TDF to TAF are reversible when treatment is changed back to TDF

News
10 December 2019
Resistance

WHO unveils plan to tackle rising HIV drug resistance in Africa

Editor's pick
World Health Organization
9 December 2019
People & personal stories

Living with HIV: 'The first question I always get asked is: are you going to die?'

Editor's pick
The Guardian
9 December 2019
PrEP policies & guidelines

A better way for the Trump administration to end HIV/AIDS

Editor's pick
The Washington Post
9 December 2019
The search for a cure

Will post-treatment controllers guide us towards an HIV cure?

News
9 December 2019
PrEP policies & guidelines

The Government's Free PrEP Isn't (Necessarily) Free

Editor's pick
TheBody
6 December 2019
Neurological & cognitive problems

Exploring the impact of aging on the brains of HIV-positive and HIV-negative people

Editor's pick
CATIE
6 December 2019
Harm reduction

Taking Naloxone where it matters

Editor's pick
Addaction / Medium
6 December 2019
Transgender people

The End of NYC’s HIV Epidemic Is In Sight—Except for Trans Women

Editor's pick
Filter
6 December 2019
Combatting stigma

Ending stigma and discrimination is critical to expanding HIV services in Jamaica

Editor's pick
UNAIDS
6 December 2019
Mental & emotional health & wellbeing

Impact of isolation and loneliness on older people living with HIV

Editor's pick
i-Base
6 December 2019
Pharmaceutical industry

Gilead delayed safer HIV drug to extend monopoly profits, advocates allege

Editor's pick
San Francisco Chronicle
6 December 2019
Undetectable viral load & treatment as prevention

Awareness of U=U increasing, but HIV-negative MSM still less likely to believe in its accuracy

News
6 December 2019